Personalized Medicine

New York – September 22, 2026 -- NYU Langone Health's Perlmutter Cancer Center has appointed Rutika Mehta, MD, MPH, as director of upper GI medical oncology, expanding its clinical and research programs for esophageal and stomach cancers.

Mehta brings a clinical trials portfolio built at two prior academic centers

Mehta joins from Weill Cornell Medicine, where she established an Upper GI Working Group to advance clinical and research collaboration. She previously helped build the Upper GI Malignancies Program at Moffitt Cancer Center in Tampa, Florida, developing a clinical trials portfolio that gave patients access to new treatment options.

Colorado Springs – September 18, 2026 -- Prime IV Hydration & Wellness has added Bioidentical Hormone Replacement Therapy (BHRT) and Niagen, a patented NAD+ precursor, to its service menu at select locations across its 215-plus site franchise network.

Prime IV expands physician-guided hormone therapy to address andropause and menopause symptoms

The BHRT program uses compounded bioidentical hormones delivered via a 100% USDA Certified Organic, solvent-free topical base designed for rapid absorption and minimized transfer risk. The offering includes initial consultation, personalized treatment planning, and ongoing provider access, targeting symptoms such as fatigue, mood changes, sleep disruption, brain fog, low libido, weight changes and decreased vitality. Prime IV has structured separate membership tracks for men and women to address andropause and perimenopause/menopause respectively.

Louisville, Ky. – September 14, 2026 -- Induction Therapies and Collagen P.I.N., in partnership with aesthetic physician Dr. Shino Bay Aguilera, released new clinical findings on a treatment protocol combining Collagen P.I.N. microneedling with PRX8, a plant-derived exosome serum, for melasma in a patient with Fitzpatrick skin type V.

Patient shows sustained improvement after four treatments over eight weeks

The case involved a woman with longstanding facial melasma who had previously used topical hydroquinone and tranexamic acid without full resolution. She underwent four Collagen P.I.N. treatments over an eight-week period, with TRUExosomes PRX8 Plant-Exo Stimulation Serum applied after each session and daily sunscreen maintained throughout.

Visible improvement in the appearance of melasma was observed across the treatment course and persisted at the two-week follow-up after the final treatment, with no adverse reactions reported.